These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 26607030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA.
    J Am Coll Cardiol; 2017 Jun 13; 69(23):2779-2790. PubMed ID: 28595692
    [Abstract] [Full Text] [Related]

  • 8. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
    Hawkins NM, Jhund PS, Pozzi A, O'Meara E, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, Virani S, McMurray JJ.
    Eur J Heart Fail; 2016 Sep 13; 18(9):1162-71. PubMed ID: 27594177
    [Abstract] [Full Text] [Related]

  • 9. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
    Borne RT, O'Donnell C, Turakhia MP, Varosy PD, Jackevicius CA, Marzec LN, Masoudi FA, Hess PL, Maddox TM, Ho PM.
    BMC Cardiovasc Disord; 2017 Sep 02; 17(1):236. PubMed ID: 28865440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M, Gabriels J, Khan M, Shaban N, D'Amato S, Liu CF, Markowitz SM, Ip JE, Thomas G, Singh P, Lerman B, Patel A, Cheung JW.
    Heart Rhythm; 2018 Apr 02; 15(4):496-502. PubMed ID: 29605015
    [Abstract] [Full Text] [Related]

  • 12. Prescribing of Direct Oral Anticoagulants in Atrial Fibrillation Based on Estimation of Renal Function Using Standard and Modified Cockcroft-Gault Equations: A Retrospective Analysis.
    Kucey M, Bolt J, Albers L, Bell A, Iroh N, Toppings J.
    Can J Hosp Pharm; 2016 Apr 02; 69(5):409-414. PubMed ID: 27826159
    [No Abstract] [Full Text] [Related]

  • 13. Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK.
    García Rodríguez LA, Martín-Pérez M, Vora P, Roberts L, Balabanova Y, Brobert G, Fatoba S, Suzart-Woischnik K, Schaefer B, Ruigomez A.
    BMJ Open; 2019 Sep 20; 9(9):e031341. PubMed ID: 31542760
    [Abstract] [Full Text] [Related]

  • 14. Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation.
    Ferreira J, Mirco A.
    Rev Port Cardiol; 2015 Mar 20; 34(3):179-91. PubMed ID: 25727748
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparison of the cost-utility of direct oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in Spain].
    Monreal-Bosch M, Soulard S, Crespo C, Brand S, Kansal A.
    Rev Neurol; 2017 Mar 16; 64(6):247-256. PubMed ID: 28272725
    [Abstract] [Full Text] [Related]

  • 17. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY, Mitchell SA, Liu X, Liu LZ, Phatak H, Kachroo S, Batson S.
    Int J Cardiol; 2016 Feb 01; 204():88-94. PubMed ID: 26655548
    [Abstract] [Full Text] [Related]

  • 18. Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France.
    Collings SL, Vannier-Moreau V, Johnson ME, Stynes G, Lefèvre C, Maguire A, Asmar J, Bizouard G, Duhot D, Mouquet F, Fauchier L.
    Arch Cardiovasc Dis; 2018 May 01; 111(5):370-379. PubMed ID: 29398546
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
    Mugnai G, de Asmundis C, Iacopino S, Stroker E, Longobardi M, De Regibus V, Coutino-Moreno HE, Takarada K, Choudhury R, Abugattas de Torres JP, Storti C, Brugada P, Chierchia GB.
    Am J Cardiol; 2017 Jul 15; 120(2):223-229. PubMed ID: 28532773
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation.
    Jelonek O, Gorczyca I, Bączek M, Kośmider P, Wożakowska-Kapłon B.
    Kardiol Pol; 2018 Jul 15; 76(7):1073-1080. PubMed ID: 29441513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.